(Photo Courtesy: www.udupitoday.com)
Sanofi Pasteur, the vaccines division of Sanofi, announced that the first shipment of ShanIPV, a brand new injectable, inactivated polio vaccine (IPV) manufactured by its affiliate Shantha Biotechnics, in Hyderabad, India, will occur in a couple of days.
These first vaccine doses will be available to implement one dose of IPV in India's immunization schedule for all infants.
Today, India is officially introducing IPV in their national immunization schedule, to supplement the iconic "drops on sugar" of oral polio vaccine (OPV).
Over 20 million newborns will eventually benefit from this new vaccine every year.
This is a critical step towards a polio-free future, a prospect that is now very close.
India's 2014 certification as polio-free reassured experts that the decades-long global fight against polio was finally drawing to an end.